With decades of experience in interventional cardiology, structural heart, and cardiac imaging, we’re committed to advancing patient outcomes. Join us at TCT 2025 in San Francisco, Oct 25–28. https://ow.ly/YKFk50XeRv4 #...
Press releases
-
ICON reports fourth quarter and full year 2019 results
ICON reports Q4 & 2019 results. Full year reported revenue was $2,806 million. This represents a year on year increase of 8.1% or 9.6% on a constant currency basis
-
ICON wins Best Contract Research Organisation – Full-Service Providers at the 15th Annual Scrip Awards 2019
ICON awarded for capabilities and innovations in successful drug development and patient recruitment
-
ICON’s acquisition of Symphony Clinical Research
The acquisition further enhances ICON’s patient, site and data strategy and complements ICON’s existing PMG Research and MeDiNova Research site networks in the US and EMEA.
-
ICON announces the appointment of Ms. Julie O’Neill to Board of Directors
And confirms the retirement of Professor Dermot Kelleher and Mr. Declan McKeon
-
Forbes names ICON in list of Best Employers in America for Women
ICON recognised as top employer for women in anonymous survey of 60,000 employees.
-
ICON’s acquisition of MeDiNova Research
The acquisition further enhances ICON’s patient recruitment capabilities in EMEA and complements ICON’s existing site network in the US, PMG Research.
-
ICON awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards
-
ICON launches new patient engagement platform to support improved patient experience & enrolment in clinical trials
Increasing visibility of potential study participants to sites and sponsors.
-
Forbes names ICON one of the best employers in America
ICON ranked top CRO in anonymous survey of 50,000 employees across 38 sectors
-
ICON wins multiple categories in 2019 CRO Leadership Awards
ICON recognised for specialised services offering across product development lifecycle
